Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases

Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases

(1) Background: Stereotactic body radiotherapy (SBRT) for vertebral metastases (VM) allows the delivery of high radiation doses to tumors while sparing the spinal cord. We report a new approach to clinical target volume (CTV) delineation based on anti-carcinoembryonic antigen (CEA) positron emission...

Full description

Bibliographic Details
Main Authors: Baptiste Pichon, Caroline Rousseau, Audrey Blanc-Lapierre, Gregory Delpon, Ludovic Ferrer, Vincent Libois, Matthieu Le Turnier, Cédric Lenoble, Caroline Bodet-Milin, David M. Goldenberg, Françoise Kraeber-Bodere, Stéphane Supiot
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Biomedicines
Subjects:
immuno-PET
CEA
bispecific antibody
stereotactic body radiation therapy (SBRT)
vertebral metastases
PET-CT
Online Access:https://www.mdpi.com/2227-9059/8/12/548

Internet

https://www.mdpi.com/2227-9059/8/12/548

Similar Items